[{"type": "title", "data": "CARD Heart Failure Management (Module) (Version 1.79)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Use clinical criteria to determine functional levels and staging "}, {"type": "note", "data": "For patients with reduced EF (Left Ventricular Ejection Fraction less than or equal to 40%) who are hemodynamically stable "}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Vital Signs (VS)", "value": "checked"}, {"type": "sentence", "data": "T;N, QID for 48 hr, If V/S stable after 48hrs, assess daily"}, {"type": "sentence", "data": "T;N, QID, Constant Order"}, {"type": "sentence", "data": "T;N, q6hr"}, {"type": "order", "data": "Oxygen Therapy (O2)", "value": "checked"}, {"type": "sentence", "data": "T;N, 6 L/min, Nasal Cannula, Constant Order, Titrate to keep SP02  90% or greater"}, {"type": "order", "data": "Weight (Wt)", "value": "checked"}, {"type": "sentence", "data": "T;N, qAM, Standing weight preferred, after voiding, before breakfast. Notify MRP if greater than 2 kg weight increase in past 48 hours."}, {"type": "order", "data": "Intake and Output (I&amp;O)", "value": "checked"}, {"type": "sentence", "data": "Daily"}, {"type": "sentence", "data": "q12hr"}, {"type": "order", "data": "Saline Lock (SL) IV", "value": "checked"}, {"type": "order", "data": "Notify Provider", "value": "checked"}, {"type": "sentence", "data": "If symptomatic hypotension"}, {"type": "order", "data": "Heart Failure Education", "value": "checked"}, {"type": "sentence", "data": "T;N, Constant Order, Provide patient with Cardiac Rehabilitation Rack Card"}, {"type": "order", "data": "Patient Education", "value": "checked"}, {"type": "sentence", "data": "T;N, Nurse to provide regarding daily weight monitoring, fluid restriction, sodium restriction, activity, immunizations, medications, smoking cessation"}, {"type": "category", "data": "Activity"}, {"type": "order", "data": "Activity as Tolerated (AAT)", "value": ""}, {"type": "order", "data": "Bedrest (BR)", "value": ""}, {"type": "sentence", "data": "T;N, Constant Order, With bathroom privileges"}, {"type": "category", "data": "Diet/Nutrition"}, {"type": "order", "data": "Fluid Restriction", "value": ""}, {"type": "sentence", "data": "T;N, Total fluids no more than 1500 ml"}, {"type": "sentence", "data": "T;N, Total fluids no more than 1750 ml"}, {"type": "sentence", "data": "T;N, Total fluids no more than 2000 ml"}, {"type": "order", "data": "Cardiac Diet", "value": ""}, {"type": "sentence", "data": "T;N, Fluid: 1500 cc's, Na: Low"}, {"type": "sentence", "data": "T;N, Fluid: 2000 cc's, Na: Low"}, {"type": "order", "data": "Low Sodium (Na) Diet", "value": ""}, {"type": "sentence", "data": "Na: Low"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "<FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>For patients with reduced EF (Left Ventricular Ejection Fraction less than or equal to 40%) who are hemodynamically stable</FONT> "}, {"type": "note", "data": "Special Authority required for carvedilol"}, {"type": "note", "data": "<FONT style=&quot;BACKGROUND-COLOR: #d282d2&quot;><FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>carvedilol usual <STRONG>starting dose</STRONG> 3.125 mg PO BID <STRONG>target dose</STRONG> 25 mg BID (if weight greater than 85 kg, <STRONG>target dose</STRONG> 50 mg PO BID)</FONT></FONT>"}, {"type": "order", "data": "carvedilol", "value": ""}, {"type": "sentence", "data": "3.125 mg, PO, Tab, BID(with meals), 180 day(s)"}, {"type": "sentence", "data": "6.25 mg, PO, Tab, BID(with meals), 180 day(s)"}, {"type": "sentence", "data": "12.5 mg, PO, Tab, BID(with meals), 180 day(s)"}, {"type": "sentence", "data": "25 mg, PO, Tab, BID(with meals), 180 day(s)"}, {"type": "sentence", "data": "50 mg, PO, Tab, BID(with meals), 180 day(s)"}, {"type": "note", "data": "<FONT style=&quot;BACKGROUND-COLOR: #ffffff&quot;></FONT><P><FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>bisoprolol usual<STRONG> starting dose</STRONG> 1.25 to 2.5 mg PO Daily,<STRONG> target dose</STRONG> 10 mg PO Daily</FONT></P>"}, {"type": "order", "data": "bisoprolol", "value": ""}, {"type": "sentence", "data": "1.25 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "2.5 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "5 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "7.5 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "10 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "note", "data": "metoprolol usual <STRONG>starting dose</STRONG> 6.25 to 12.5 mg PO BID, <STRONG>target dose</STRONG> 100 mg PO BID"}, {"type": "order", "data": "metoprolol", "value": ""}, {"type": "sentence", "data": "6.25 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "12.5 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "25 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "50 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "100 mg, PO, Tab, BID, 180 day(s)"}, {"type": "note", "data": "<P><FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>For symptomatic patients with heart failure with EF 40% or less and class II-IV symptoms, order spironolactone</FONT></P>"}, {"type": "note", "data": "ramipril usual<STRONG> starting dose</STRONG> 1.25 to 2.5 mg, <STRONG>target dose</STRONG> 5 mg PO BID "}, {"type": "order", "data": "ramipril", "value": ""}, {"type": "sentence", "data": "1.25 mg, PO, Cap, BID, 180 day(s)"}, {"type": "sentence", "data": "2.5 mg, PO, Cap, BID, 180 day(s)"}, {"type": "sentence", "data": "5 mg, PO, Cap, BID, 180 day(s)"}, {"type": "note", "data": "perindopril usual <STRONG>starting dose</STRONG> 2 mg,<STRONG> target dose</STRONG> 8 mg PO Daily"}, {"type": "order", "data": "perindopril", "value": ""}, {"type": "sentence", "data": "2 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "4 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "8 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "note", "data": "Avoid combination of ACEi Inhibitor with an ARB "}, {"type": "note", "data": "Special Authority required for all Angiotensin Receptor Blockers "}, {"type": "note", "data": "candesartan usual <STRONG>starting dose</STRONG> 4 mg to 8 mg Daily,<STRONG> target dose</STRONG> 32 mg PO Daily "}, {"type": "order", "data": "candesartan", "value": ""}, {"type": "sentence", "data": "4 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "8 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "16 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "32 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "note", "data": "valsartan usual<STRONG> starting dose</STRONG> 40 mg BID, <STRONG>target dose</STRONG> 160 mg PO BID"}, {"type": "order", "data": "valsartan", "value": ""}, {"type": "sentence", "data": "40 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "80 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "160 mg, PO, Tab, BID, 180 day(s)"}, {"type": "order", "data": "furosemide", "value": ""}, {"type": "sentence", "data": "40 mg, IV Piggyback, Injection, q24hr(sched), 180 day(s)"}, {"type": "sentence", "data": "40 mg, IV Piggyback, Injection, BID, 180 day(s)"}, {"type": "sentence", "data": "80 mg, IV Piggyback, Injection, q24hr(sched), 180 day(s)"}, {"type": "sentence", "data": "80 mg, IV Piggyback, Injection, BID, 180 day(s)"}, {"type": "order", "data": "furosemide", "value": ""}, {"type": "sentence", "data": "40 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "40 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "80 mg, PO, Tab, BID, 180 day(s)"}, {"type": "order", "data": "furosemide", "value": ""}, {"type": "sentence", "data": "1 mg/kg, IV Piggyback, Injection, Once, 180 day(s)"}, {"type": "sentence", "data": "mg, IV Piggyback, Injection, Once"}, {"type": "order", "data": "metOLazone 2.5 mg oral tablet", "value": ""}, {"type": "sentence", "data": "2.5 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "2.5 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "5 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "5 mg, PO, Tab, BID, 180 day(s)"}, {"type": "note", "data": "<FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>Consider hydrALAZINE and&nbsp; nitrates if renal impairment or other intolerance to ACEi and ARBs</FONT> "}, {"type": "note", "data": "hydrALAZINE usual <STRONG>starting dose</STRONG> 10 mg PO TID,<STRONG> maximum dose</STRONG> 100 mg PO TID "}, {"type": "order", "data": "hydrALAZINE", "value": ""}, {"type": "sentence", "data": "10 mg, PO, Tab, TID, 180 day(s)"}, {"type": "sentence", "data": "25 mg, PO, Tab, TID, 180 day(s)"}, {"type": "sentence", "data": "50 mg, PO, Tab, TID, 180 day(s)"}, {"type": "sentence", "data": "75 mg, PO, Tab, TID, 180 day(s)"}, {"type": "sentence", "data": "100 mg, PO, Tab, TID, 180 day(s)"}, {"type": "note", "data": "AVOID nitrates if any of the following are present:&nbsp; -Systolic blood pressure below 90 mmHg OR if more than 30 mmHg drop from baseline&nbsp;&nbsp; -Suspected right ventricular infarction&nbsp; -Recent use of phosphodiesterase inhibitors: within 24 hrs for sildenafil (VIAGRA) and vardenafil (LEVITRA), within 48 hrs for tadalafil (CIALIS) "}, {"type": "note", "data": "isosorbide dinitrate usual <STRONG>starting dose</STRONG> 10mg PO TID, <STRONG>maximum dose</STRONG> 40mg PO TID "}, {"type": "order", "data": "isosorbide dinitrate", "value": ""}, {"type": "sentence", "data": "10 mg, PO, Tab, TID, 180 day(s)"}, {"type": "sentence", "data": "20 mg, PO, Tab, TID, 180 day(s)"}, {"type": "sentence", "data": "30 mg, PO, Tab, TID, 180 day(s)"}, {"type": "sentence", "data": "40 mg, PO, Tab, TID, 180 day(s)"}, {"type": "order", "data": "nitroglycerin 0.2 mg/hr transdermal film, extended release", "value": ""}, {"type": "sentence", "data": "0.2 mg/hr, Topically, Patch, Daily, 180 day(s)"}, {"type": "order", "data": "nitroglycerin 0.4 mg/hr transdermal film, extended release", "value": ""}, {"type": "sentence", "data": "0.4 mg/hr, Topically, Patch, Daily, 180 day(s)"}, {"type": "order", "data": "nitroglycerin 0.6 mg/hr transdermal film, extended release", "value": ""}, {"type": "sentence", "data": "0.6 mg/hr, Topically, Patch, Daily, 180 day(s)"}, {"type": "order", "data": "nitroglycerin 0.8 mg/hr transdermal film, extended release", "value": ""}, {"type": "sentence", "data": "0.8 mg/hr, Topically, Patch, Daily, 180 day(s)"}, {"type": "note", "data": "For symptomatic patients with heart failure with EF 40% or less and class II-IIIa symptoms, order spironolactone "}, {"type": "note", "data": "Caution if eGFR below 30 mL/min and/or potassium above 5 mmol/L"}, {"type": "note", "data": "Spironolactone usual<STRONG> starting dose</STRONG> 12.5mg PO Daily, <STRONG>maximum dose</STRONG> 50mg PO Daily"}, {"type": "order", "data": "spironolactone", "value": ""}, {"type": "sentence", "data": "12.5 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "25 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "50 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "note", "data": "Avoid using NSAIDs, steroids, non-dihydropyridine calcium channel blockers, rosiglitazone AND/OR pioglitazone "}, {"type": "note", "data": "If beta blocker not ordered, document contraindication"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "BNP", "value": "checked"}, {"type": "sentence", "data": "Blood, Routine collect, T;N, Once"}, {"type": "order", "data": "BNP Whole Blood", "value": "checked"}, {"type": "sentence", "data": "Blood, Routine collect, T;N, Once"}, {"type": "category", "data": "Diagnostic Tests"}, {"type": "note", "data": "<FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>If not done on this admission consider the below</FONT> "}, {"type": "order", "data": "XR Chest 1", "value": ""}, {"type": "sentence", "data": "T;N, P1 &lt; 24 hours"}, {"type": "order", "data": "ECG Standard 12-Lead", "value": "checked"}, {"type": "sentence", "data": "T;N, P1 - STAT"}, {"type": "note", "data": "Repeat echocardiogram only if no recent assessment of LV function performed in past 12 months AND clinical status change warrants investigation "}, {"type": "order", "data": "US Cardiac Realtime &amp; Doppler", "value": "checked"}, {"type": "sentence", "data": "T;N, P1 &lt; 24 hours"}, {"type": "category", "data": "Respiratory"}, {"type": "order", "data": "Continuous Positive Airway Pressure (CPAP)/Bilevel Positive Airway Pressure (BiPAP) Home Settings", "value": ""}, {"type": "category", "data": "Consults/Referrals"}, {"type": "order", "data": "Consult to Dietitian Adult", "value": ""}, {"type": "order", "data": "Consult to Pharmacy", "value": ""}, {"type": "order", "data": "Consult to Physical Therapy (PT)", "value": ""}, {"type": "order", "data": "Consult to Registered Respiratory Therapy (RRT)", "value": ""}, {"type": "order", "data": "Consult to Indigenous Care Coordinator", "value": ""}, {"type": "order", "data": "Consult to Social Worker (SW)", "value": ""}, {"type": "order", "data": "Consult to Palliative Care Consultation Team", "value": ""}, {"type": "order", "data": "Consult to Adult Mental Health", "value": ""}, {"type": "order", "data": "Consult to Spiritual Health Services", "value": ""}, {"type": "order", "data": "Consult to NORTH Heart Function Clinic", "value": ""}, {"type": "order", "data": "Consult to Physician", "value": ""}, {"type": "sentence", "data": "Family Practice"}]
